Related Experiment Videos
Interferon induces pulmonary cysts in A2G mice.
Summary
Early life exposure to alpha/beta interferon in A2G mice caused severe pulmonary cysts. This interferon-induced disease was dependent on the specific mouse genotype, highlighting genetic susceptibility.
Area of Science:
- Immunology
- Genetics
- Developmental Biology
Background:
- Alpha/beta interferons are critical for innate immunity.
- Early life exposure to immune modulators can have long-term effects.
- Genetic background influences disease susceptibility.
Purpose of the Study:
- To investigate the impact of early-life alpha/beta interferon exposure on mouse development.
- To determine if mouse genotype affects the outcome of interferon treatment.
- To characterize the resulting pathology in susceptible mice.
Main Methods:
- Suckling A2G mice were treated with mouse alpha/beta interferon during the first week of life.
- Interferon treatment was administered using partially purified or electrophoretically pure preparations.
- Control groups included Swiss, BALB/c, and F1 Swiss/A2G mice treated with interferon.
Main Results:
- All interferon-treated A2G mice developed multiple large pulmonary cysts.
- Pulmonary lesions were absent in interferon-treated Swiss mice.
- Lesions were infrequent in interferon-treated BALB/c and F1 Swiss/A2G mice.
Conclusions:
- A brief neonatal exposure to alpha/beta interferon can induce severe pulmonary disease in A2G mice.
- The development of interferon-induced pulmonary cysts is strongly determined by mouse genotype.
- This study reveals a genotype-specific susceptibility to interferon-induced pathology in early life.